Comparison of CL Wear Between Two Allergy Drops

Hom, Milton M., OD, FAAO

Status and phase: Withdrawn; Phase 4

Conditions: Allergic Conjunctivitis

Treatments: Drug: epinastine HCL and olopatadine HCL

Study type: Interventional

Funder types: Industry

Identifiers

NCT00489398

5316

Details and patient eligibility

About

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

Full description

Contact lens patients will instill allergy drops and subjective and objective tests will be performed

Enrollment: 25 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Males or females > 18 years old
• Mild to moderate dry eye symptoms
• Likely to complete all study visits and able to provide informed consent

Exclusion criteria

• Current use of topical cyclosporine
• Known contraindications to any study medication or ingredients
• Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
• Ocular surgery within the past 3 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind